Skip to main content
Equibles

Mark Mazzaro

Analyst

BTIG

Equibles does not estimate personal net worth.

About Mark Mazzaro

Mark Mazzaro is recorded as Analyst at BTIG. Mark Mazzaro has spoken on 4 earnings calls across 4 companies, most recently for Adaptive Biotechnologies Corp on May 5, 2026. Those appearances were for Adaptive Biotechnologies Corp (ADPT), SOPHiA GENETICS SA (SOPH), Personalis, Inc. (PSNL) and Insight Molecular Diagnostics Inc. (IMDX). The companies whose calls Mark Mazzaro spoke on are classified in the Healthcare sector.

Mark Mazzaro on recent calls

“I wanted to start on the pharma backlog, which increased 24% year over year. And like David said, it's great to see the first primary milestone come in. And so I think in prior quarters, you've sort of broken out the secondary versus primary funnel.”
Analyst — BTIG, Adaptive Biotechnologies Corp Q1 FY2026 Earnings Call ·
“Yergi, I appreciate the network that you've built globally to decentralize this testing and look forward to working with you as you move to the executive chairman role.”
Analyst — BTIG, SOPHiA GENETICS SA Q1 FY2026 Earnings Call ·
“Thank you for taking the questions. um uh yeah great to see the progress um i just wanted to start and i apologize if this is nitpicky the um the next personal growth was just a hair shy of your previously communicated 30 to 40 percent a quarter growth uh coming in at plus 26 um i'm just curious if that is largely due…”
Analyst — BTIG, Personalis, Inc. Q3 FY2025 Earnings Call ·
“So I wanted to ask about the regulatory pathway. I think in the pre-sub, the FDA indicated you can use the de novo pathway and likely not the 510K pathway.”
Analyst — BTIG, Insight Molecular Diagnostics Inc. Q4 FY2024 Earnings Call ·

Affiliation history

  • BTIG

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity